The article you requested is

Initial Evidence of the Beneficial Effects of Glutamate-Modulating Agents in the Treatment of Self-Injurious Behavior Associated With Borderline Personality Disorder

Christopher Pittenger, MD, PhD; John H. Krystal, MD; and Vladimir Coric, MD

J Clin Psychiatry 2005;66(11):1492-1493 [letter]

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Self-injurious behavior (SIB) in patients with borderline personality disorder (BPD), especially cutting, represents a serious and often intractable clinical problem.1 There are few validated pharmacologic strategies for managing SIB.1–3 We describe our initial experience using glutamate-modulating agents in 2 patients with BPD and prominent SIBs.​